Following major breakthroughs made at Massachusetts Institute of Technology, there has been good reason to get excited about yeast models in the medical community, it has been said.
The Parkinson's Disease Society made its comments about the future of elderly care and how it may be changed if the "incredibly useful" yeast cell research is further studied by teams of researchers around the world.
It explained that genes and proteins work in specific ways when inside affected cells, with yeast able to bring about a number of changes and illustrations of these relationships.
Commenting on the developments, Dr Kieran Breen, the director of research at the Parkinson's Disease Society, said: "This research is exciting because it has found molecules that can directly target the cause of nerve cell death.
"Using yeast models to screen for molecules will accelerate the search for new Parkinson's drugs and a cure for Parkinson's."
Earlier in the month, the charity announced that Neupro, a drug to treat Parkinson's disease, is now back on the market after the European Commission lifted treatment restrictions on it.
Please click here for advice to help you find the right type of care.